Danaher Corporation / Cytiva (Whatman brand)

What they make

4 inputs Danaher Corporation / Cytiva (Whatman brand) supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Concentration2024

  Danaher Corporation — a Washington DC-based industrial conglomerate known for precision instruments — controls an extraordinary concentration of IVD supply chain chokepoints through acquisitions: Cytiva/Whatman (nitrocellulose membranes, glass fiber pads), IDT/Integrated DNA Technologies (oligonucleotide probes), Pall Corporation (filtration media), and IDEX Health & Science (microfluidic components). A single conglomerate now owns multiple independent critical nodes across the IVD manufacturing supply chain.

  Danaher Corporation ↗

• Did you know2023

  Danaher's IDT (Integrated DNA Technologies) — acquired in 2021 — is the world's largest supplier of custom oligonucleotides AND the dominant supplier of guide RNAs for CRISPR gene editing. IDT's Alt-R CRISPR-Cas9 system is used in the majority of academic and industrial CRISPR research programs globally. Every CRISPR-based gene therapy program, every CRISPR diagnostic (like Mammoth's Cas12 detection system), and virtually every published CRISPR paper uses IDT guide RNAs. Meanwhile, IDT's parent Danaher also owns Cytiva (Whatman nitrocellulose membranes for COVID rapid tests) and Pall Corporation (sterilizing filters for vaccine fill-finish). One conglomerate supplies the guide RNA for CRISPR therapeutics (IDT), the membrane for the COVID test that diagnoses disease (Cytiva), and the filter that sterilizes the COVID vaccine that treats it (Pall) — three completely separate supply chains in one Danaher holding company.

  Integrated DNA Technologies (Danaher) ↗

• Origin2023

  Danaher Corporation transformed from a Washington DC-based industrial tools conglomerate (Fluke electrical meters, Craftsman tools, Hach water testing) into one of the most strategically positioned life science supply chain companies through a series of multi-billion-dollar acquisitions: Pall Corporation ($13.6B, 2015 — filtration), Beckman Coulter ($6.8B, 2011 — diagnostics), Cepheid ($4B, 2016 — molecular diagnostics), GE Healthcare Life Sciences/Cytiva ($21.4B, 2019 — bioprocess), and IDT ($1.8B, 2021 — custom oligonucleotides/CRISPR). Each acquisition added a different chokepoint in the biotech supply chain. By 2022, a single Washington DC holding company — using the 'Danaher Business System' of lean process improvement — controlled the membranes in COVID tests, the filters in COVID vaccine manufacturing, the chromatography in antibody drug purification, and the guide RNAs in CRISPR gene editing research.

  Danaher Corporation ↗

• Capacity2023

  Danaher's Cytiva acquisition ($21.4B from GE Healthcare in 2019) was one of the largest life science deals ever — and its strategic significance was validated almost immediately by COVID-19. Cytiva's Protein A chromatography resins (MabSelect series) are used to purify virtually every monoclonal antibody drug manufactured globally. Cytiva's ReadyToProcess bioreactor systems, single-use bags, and ÄKTA purification systems represent the core bioprocessing infrastructure of the global biopharma industry. During COVID-19, Cytiva's single-use manufacturing volumes surged to supply vaccine production. Separately, Cytiva's Whatman NC membranes were supply-constrained for rapid test manufacturing. Danaher paid $21.4B in 2019 and the acquisition immediately became critical infrastructure for the global pandemic response — validating the thesis that bioprocessing supply chains are strategic assets.

  Cytiva (Danaher Corporation) ↗